Enterobiasis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 31: | Line 31: | ||
| align="center" style="background:#DCDCDC;" | Hemorrhoids(internal or external) | | align="center" style="background:#DCDCDC;" | Hemorrhoids(internal or external) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Bright red blood on toilet paper/stool | * Bright red blood on toilet paper/stool. | ||
* Pain with defecation | * Pain with defecation. | ||
* Painful lump in the anal area | * Painful lump in the anal area. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Thrombocytopenia]], [[leukocytosis]], [[leukopenia]], elevated [[Creatinine|Cr]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Thrombocytopenia]], [[leukocytosis]], [[leukopenia]], elevated [[Creatinine|Cr]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 39: | Line 39: | ||
| align="center" style="background:#DCDCDC;" | Anal fissure | | align="center" style="background:#DCDCDC;" | Anal fissure | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Bright red blood on toilet paper/stool | * Bright red blood on toilet paper/stool. | ||
* Pain with defecation | * Pain with defecation. | ||
* Anal tears | * Anal tears. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hypercarbia]] (PaCO2) >65 mmHg, [[hyperkalemia]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hypercarbia]] (PaCO2) >65 mmHg, [[hyperkalemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of receiving anaesthetic agent | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of receiving anaesthetic agent | ||
Line 48: | Line 48: | ||
| align="center" style="background:#DCDCDC;" | Bacterial | | align="center" style="background:#DCDCDC;" | Bacterial | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Skin edema, erythema, and warmth | * Skin edema, erythema, and warmth. | ||
* Pruritis, pain, and discharge from the lesions. | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]], [[leukocytosis]], [[myoglobinuria]]. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]], [[leukocytosis]], [[myoglobinuria]]. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Relevant history of recent use of anti-psychotics | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Relevant history of recent use of anti-psychotics | ||
Line 54: | Line 55: | ||
| align="center" style="background:#DCDCDC;" | Candidal | | align="center" style="background:#DCDCDC;" | Candidal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Erythematous skin plaques and erosions with peripheral scaling | * Erythematous skin plaques and erosions with peripheral scaling. | ||
* Pruritus on the skin plaques. | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | ||
Line 60: | Line 62: | ||
| align="center" style="background:#DCDCDC;" |Scabies | | align="center" style="background:#DCDCDC;" |Scabies | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Erythematous papules with hemorrhagic crustings | * Erythematous papules with hemorrhagic crustings. | ||
* Pruritus, pain, and bleeding from papules | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" | | | align="center" style="background:#DCDCDC;" |HPV | ||
(Condylomata | |||
acuminata) | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * Soft papules/plaques in the anogenital area. | ||
* Pruritus, pain, and bleeding from papules | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. |
Revision as of 15:08, 23 June 2017
Enterobiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Enterobiasis differential diagnosis On the Web |
American Roentgen Ray Society Images of Enterobiasis differential diagnosis |
Risk calculators and risk factors for Enterobiasis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Enterobiasis must be differentiated from other nematode infections.
Differentiating Enterobiasis from other diseases
The table below summarizes the findings that differentiate enterobiasis from other nematode infections.
References
|